Interestingly, despite the benefit of CD34+ve exosomes observed on angiogenesis, CD34+ve hematopoietic stem cells were not cardioprotective when administered after acute myocardial infarction unless engineered to express sonic hedgehog (Shh) [45]. Here, CD34 is linked to acute myocardial infarction.